tweetindex
IT

Avi 🥞 ✓

@AviNMash · New York City, NY · joined 25 Mar 2010

Co-Founder @21RatesHQ and @MeetScanley | Hosting @DailyStackHQ Deep stock research + Bitcoin | BTC class 2017

14 422Followers
2 503Following
25 244Posts total
48.4KViews on collected posts

Ultimi post

About to go live with @JFDI and @DayTraderCaleb and at 1:30pm @ProblemSniper on @DailyStackHQ 3.8K views · 4 likes · 2 reposts · 1 replies Open on X →
Throwback to @nickshirleyy wow… Greatest journalist in our generation? https://t.co/0jFXDegMAE
1.2K views · 1 likes · 0 reposts · 1 replies Open on X →
$IOVA is up 243% this year, and I think we’re just getting started The next 90 days are massive. By end of Sept they will be updating guidance Q2 revenue came in at $99.3M, up 66% year management has already said it's reviewing and one day “you’ll wake up happy” ESMO runs 1.6K views · 30 likes · 1 reposts · 3 replies Open on X →
And we are now at $10.41.... $IOVA Discussed back in Marh at $3.24 on @DailyStackHQ 812 views · 4 likes · 0 reposts · 0 replies Open on X →
@AviNMash Avi , great great article thank you, the private venture portfolio is part of $NBIS Or is it separate? 302 views · 2 likes · 0 reposts · 1 replies Open on X →
The stock trades near $214 today (futures were up 7% during holiday in Canada) at a $54B cap, around 17x forward sales, and CoreWeave is the comparison everyone reaches for even though CoreWeave has no venture book it can monetize or borrow against. Citi clearly sees the gap, 898 views · 7 likes · 0 reposts · 1 replies Open on X →
Most people buying $NBIS think they’re getting a pure GPU cloud, but whats often overlooked is their private venture portfolio worth close to $7B that almost no analyst bothers to put in the model. A quick backstory, since it matters here. Nebius came out of the old Yandex http
23.6K views · 174 likes · 12 reposts · 12 replies Open on X →
Was a #MiniMonster created with $IOVA on Midweek Markets with @AviNMash / @ProblemSniper and @JodyFlournoy ? Day of Recording 2/24/25 Price = $3.24 Price Today = $5.41 Iovance Biotherapeutics (IOVA) is a commercial-stage leader in cancer immunotherapy, recently achieving a h
2:22
14.1K views · 8 likes · 0 reposts · 0 replies Open on X →
Damn Nick Shirley has been doing this. 1 year ago he was talking about US buying Greenland https://t.co/7DuYWgRQ3J 2K views · 0 likes · 0 reposts · 0 replies Open on X →

Rispetto ad account della stessa dimensione

4 post degli ultimi 90 giorni, accanto alla fascia di 10K–100K follower. arriva a molti, ma pochi di loro reagiscono.

Visualizzazioni mediane1 404questo account924mediana per 10K–100K
Copertura, %9.74%questo account3.62%mediana per 10K–100K
Interazione, %0.34%questo account1.52%mediana per 10K–100K
MetricaQuesto accountMediana per 10K–100KRapporto
Visualizzazioni mediane per post1 4049241.52×
Copertura (visualizzazioni ÷ follower)9.74%3.62%2.69×
Tasso di interazione0.34%1.52%0.22×

Altri account di questa fascia →   Confronta con un altro account →   Come sono costruiti questi parametri →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

2K22 Jan
14.1K10 Mar
23.6K26 May
898
302
81217 Sep
1.6K18 Sep
1.2K19 Sep
3.8K22 Sep

Last 9 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.05%22 Jan
0.07%10 Mar
0.85%26 May
0.89%
0.99%
0.49%17 Sep
2.09%18 Sep
0.17%19 Sep
0.18%22 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes65.7%230 in total
Reposts4.3%15 in total
Replies5.4%19 in total
Quotes1.7%6 in total
Bookmarks22.9%80 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Account simili